ArticleJournal of medicinal chemistry2023

Engineered Vancomycin, with Increased Interactions with Peptidoglycan Stem Peptide, Conquers Non-tuberculosis Mycobacteria.

Christopher Vennard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.